Extended, 3-year, exenatide therapy shows sustainable effects on beta cell disposition index in metformin treated patients with type 2 diabetes
Year: 2010
Type: conference-paper
Source: Pure Amsterdam UMC
Authors: Bunck, M.C.M., Corner, A., Eliasson, B., Heine, R.J., Shaginian, R.M., Taskinen, M.R., Smith, U., Yki-Jarvinen, H., Diamant, M.
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2773688727
